NO2496261T3 - - Google Patents

Info

Publication number
NO2496261T3
NO2496261T3 NO10828966A NO10828966A NO2496261T3 NO 2496261 T3 NO2496261 T3 NO 2496261T3 NO 10828966 A NO10828966 A NO 10828966A NO 10828966 A NO10828966 A NO 10828966A NO 2496261 T3 NO2496261 T3 NO 2496261T3
Authority
NO
Norway
Application number
NO10828966A
Other languages
Norwegian (no)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NO2496261T3 publication Critical patent/NO2496261T3/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • A61K31/375Ascorbic acid, i.e. vitamin C; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
NO10828966A 2009-11-05 2010-11-02 NO2496261T3 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25839109P 2009-11-05 2009-11-05
PCT/US2010/055068 WO2011056775A2 (en) 2009-11-05 2010-11-02 Microcrystalline cellulose and calcium phosphate compositions useful as pharmaceutical excipients

Publications (1)

Publication Number Publication Date
NO2496261T3 true NO2496261T3 (de) 2018-05-19

Family

ID=43925704

Family Applications (1)

Application Number Title Priority Date Filing Date
NO10828966A NO2496261T3 (de) 2009-11-05 2010-11-02

Country Status (10)

Country Link
US (1) US8329221B2 (de)
EP (1) EP2496261B1 (de)
JP (1) JP6092626B2 (de)
BR (1) BR112012010400B1 (de)
DK (1) DK2496261T3 (de)
ES (1) ES2662698T3 (de)
IL (1) IL219374B (de)
NO (1) NO2496261T3 (de)
TW (1) TWI461213B (de)
WO (1) WO2011056775A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906949B2 (en) * 2010-05-21 2014-12-09 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Orally disintegrating tablets of zolmitriptan and process for preparing the same
US10793847B2 (en) * 2015-05-11 2020-10-06 Mybiotics Pharma Ltd. Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut
PL3697392T3 (pl) 2017-10-17 2024-03-25 Synthon B.V. Tabletki zawierające tamsulosynę i solifenacynę
CN108815125A (zh) * 2018-07-23 2018-11-16 深圳市优普惠药品股份有限公司 微晶纤维素与无水磷酸氢钙复合物及其制备工艺
CA3107696A1 (en) 2018-10-04 2020-04-09 Chemische Fabrik Budenheim Kg Spherical beads for use in producing pharmaceutically active pellets
EP3892262A1 (de) 2020-04-06 2021-10-13 Chemische Fabrik Budenheim KG Kügelchen mit puffersystem

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1981002521A1 (en) 1980-03-10 1981-09-17 Mendell Co Inc Edward Pharmaceutical vehicle composition and process of producing same
US4517179A (en) 1983-04-29 1985-05-14 Pennwalt Corporation Rapid dissolving, uniform drug compositions and their preparation
CA1261261A (en) * 1985-03-08 1989-09-26 Dev K. Mehra Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
US6936277B2 (en) 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6123964A (en) 1995-10-27 2000-09-26 Merck & Co., Inc. Wet granulation formulation of a growth hormone secretagogue
US5858409A (en) 1996-04-17 1999-01-12 Fmc Corporation Hydrolyzed cellulose granulations for pharmaceuticals
US5747067A (en) 1996-12-06 1998-05-05 Fmc Corporation Co-processed products
US6103260A (en) * 1997-07-17 2000-08-15 Mcneil-Ppc, Inc. Simethicone/anhydrous calcium phosphate compositions
US6716449B2 (en) * 2000-02-08 2004-04-06 Euro-Celtique S.A. Controlled-release compositions containing opioid agonist and antagonist
AR028253A1 (es) * 2000-03-16 2003-04-30 Pfizer Prod Inc Inhibidores de la glucogeno fosforilasa
AT5874U1 (de) * 2000-12-29 2003-01-27 Bioorg Bv Pharmazeutische zubereitungen enthaltend amlodipinmaleat
EP1226818A1 (de) 2001-01-26 2002-07-31 Pfizer Products Inc. Arzneiform mit verbesserten kohäsiven und kompressiven Eigenschaften
DK1476136T3 (da) * 2002-02-14 2006-10-09 Glaxo Group Ltd Farmaceutisk præparat, der omfatter N-[(1-N-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indol-10-carboxamid eller salt, og fremgangsmåde derfor, der omfatter törgranulering
TW200403994A (en) 2002-04-04 2004-03-16 Bristol Myers Squibb Co Oral administration of EPOTHILONES
GB0211620D0 (en) 2002-05-21 2002-07-03 Bioprogress Technology Ltd Powder compaction and enrobing
GB0322358D0 (en) 2003-09-24 2003-10-22 Bioprogress Technology Ltd Improvements in powder compaction and enrobing
JP3841804B2 (ja) 2003-10-15 2006-11-08 富士化学工業株式会社 口腔内速崩壊性錠剤用の組成物
CN101065091A (zh) 2004-09-24 2007-10-31 生物进展技术有限公司 对粉末压实和包覆的额外改进
DE102005046146A1 (de) * 2005-02-25 2006-08-31 Bayerische Motoren Werke Ag Teilintegralbremse für ein Motorrad
CN101360725B (zh) * 2005-11-18 2011-09-21 阿斯利康公司 固体制剂
US7998505B2 (en) 2006-10-27 2011-08-16 Fmc Corporation Dry granulation binders, products, and use thereof
CA2644179C (en) * 2007-11-21 2018-09-25 Pharmascience Inc. Novel pharmaceutical composition comprising a disintegration matrix

Also Published As

Publication number Publication date
EP2496261A2 (de) 2012-09-12
EP2496261B1 (de) 2017-12-20
ES2662698T3 (es) 2018-04-09
WO2011056775A3 (en) 2011-11-03
JP2013510157A (ja) 2013-03-21
DK2496261T3 (en) 2018-03-26
US20110104288A1 (en) 2011-05-05
IL219374B (en) 2019-05-30
BR112012010400B1 (pt) 2019-11-05
WO2011056775A2 (en) 2011-05-12
BR112012010400A2 (pt) 2016-07-12
TW201124157A (en) 2011-07-16
IL219374A0 (en) 2012-06-28
EP2496261A4 (de) 2014-03-26
TWI461213B (zh) 2014-11-21
US8329221B2 (en) 2012-12-11
JP6092626B2 (ja) 2017-03-08

Similar Documents

Publication Publication Date Title
BR112012012396A2 (de)
BR112012008267A2 (de)
BR112012003062A2 (de)
BR112012008195A2 (de)
BR112012000607A2 (de)
BRPI0925311A2 (de)
BRPI0924307A2 (de)
BR112012003080A2 (de)
BR122021004633A2 (de)
BR122017024704A2 (de)
BR112012000665A2 (de)
BR112012003853A2 (de)
BR112012012080A2 (de)
BR112012009446A2 (de)
BR112012002627A2 (de)
BR112012001263A2 (de)
BR112012000159A2 (de)
BR112012014856A2 (de)
BRPI0924534A2 (de)
BR112012007672A2 (de)
BR112012000255A2 (de)
BR112012000156A2 (de)
BRPI0924617A2 (de)
BR122017013721A2 (de)
BR112012009404A2 (de)